| Suvorexant | IC50 | 0.4 [1], 56.0 [2], 138.0 [3] |
| Suvorexant | Ki | 0.35 [1], 0.4 [2], 11.8 [3] |
| [5-Methyl-2-(triazol-2-yl)phenyl]-(4-quinazolin-2-yl-1,4-diazepan-1-yl)methanone | IC50 | 27.0 [1] |
| [5-Methyl-2-(triazol-2-yl)phenyl]-(4-quinazolin-2-yl-1,4-diazepan-1-yl)methanone | Ki | 0.59 [1], 0.6 [2] |
| [(7R)-4-(6-Fluoroquinazolin-2-yl)-7-methyl-1,4-diazepan-1-yl]-[2-(triazol-2-yl)phenyl]methanone | IC50 | 27.0 [1] |
| [(7R)-4-(6-Fluoroquinazolin-2-yl)-7-methyl-1,4-diazepan-1-yl]-[2-(triazol-2-yl)phenyl]methanone | Ki | 0.17 [1], 0.2 [2], 1.8 [3] |
| Almorexant | IC50 | 8.0 [1], 8100.0 [2] |
| Almorexant | Ki | 4.7 [1], 8.0 [2] |
| Filorexant | IC50 | 11.0 [1], 17.0 [2] |
| Filorexant | Ki | 0.3 [1] |
| CID 25195495 | Ki | 0.4 [1], 1.29 [2], 8.5 [3] |
| 2-[(3R,6R)-6-Methyl-1-[2-(triazol-2-yl)benzoyl]piperidin-3-yl]oxypyridine-4-carbonitrile | IC50 | 9.0 [1], 13.0 [2] |
| 2-[(3R,6R)-6-Methyl-1-[2-(triazol-2-yl)benzoyl]piperidin-3-yl]oxypyridine-4-carbonitrile | Ki | 1.6 [1] |
| Urea, N-(2,4-dibromophenyl)-N'-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)- | Ki | 5.01 [1], 6.0 [2], 3162.28 [3] |
| CID 54765113 | IC50 | 417.0 [1] |
| CID 54765113 | Ki | 417.0 [1] |
| 2-[(3R,6R)-6-Methyl-1-(2-pyrimidin-2-ylbenzoyl)piperidin-3-yl]oxypyridine-4-carbonitrile | IC50 | 28.0 [1] |
| 2-[(3R,6R)-6-Methyl-1-(2-pyrimidin-2-ylbenzoyl)piperidin-3-yl]oxypyridine-4-carbonitrile | Ki | 1.3 [1] |
| Methyl 2-[(3R,6R)-6-methyl-1-[2-(triazol-2-yl)benzoyl]piperidin-3-yl]oxypyridine-4-carboxylate | IC50 | 22.0 [1] |
| Methyl 2-[(3R,6R)-6-methyl-1-[2-(triazol-2-yl)benzoyl]piperidin-3-yl]oxypyridine-4-carboxylate | Ki | 3.9 [1] |
| (2S)-N-(3,5-Dimethylphenyl)-1-[(4-methoxyphenyl)sulfonyl]-2-pyrrolidinecarboxamide | IC50 | 5.0 [1], 11.0 [2] |
| CID 10408514 | IC50 | 40.0 [1] |
| Mk-1064 | IC50 | 18.0 [1] |
| Mk-1064 | Ki | 0.5 [1] |
| MK-3697 | IC50 | 16.0 [1] |
| MK-3697 | Ki | 0.95 [1], 1.1 [2] |
| [(2S)-2-[2-(4-Fluorophenoxy)ethyl]piperidin-1-yl]-(2-methyl-5-phenyl-1,3-thiazol-4-yl)methanone | IC50 | 14.0 [1] |
| [(2S)-2-[2-(4-Fluorophenoxy)ethyl]piperidin-1-yl]-(2-methyl-5-phenyl-1,3-thiazol-4-yl)methanone | Ki | 1.0 [1] |
| (3S,5S)-5-(2,6-Dimethoxyphenyl)-3-methyl-1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrolidin-2-one | IC50 | 126.0 [1], 128.0 [2] |
| 5-(2,6-Dimethoxyphenyl)-1-(4-(trifluoromethoxy)benzyl)pyrrolidin-2-one | IC50 | 158.0 [1] |
| [(3S)-4,4-Difluoro-3-quinolin-2-yloxypiperidin-1-yl]-[2-(triazol-2-yl)phenyl]methanone | IC50 | 4184.0 [1] |
| [(3S)-4,4-Difluoro-3-quinolin-2-yloxypiperidin-1-yl]-[2-(triazol-2-yl)phenyl]methanone | Ki | 521.0 [1] |
| [(2R,5R)-5-Isoquinolin-1-yloxy-2-methylpiperidin-1-yl]-[2-(triazol-2-yl)phenyl]methanone | IC50 | 15.0 [1] |
| [(2R,5R)-5-Isoquinolin-1-yloxy-2-methylpiperidin-1-yl]-[2-(triazol-2-yl)phenyl]methanone | Ki | 0.11 [1], 0.3 [2] |
| N-[(5,6-Dimethoxypyridin-2-yl)methyl]-5-(3-fluorophenyl)-2-(5-methylpyridin-3-yl)pyridine-4-carboxamide | IC50 | 16.0 [1] |
| N-[(5,6-Dimethoxypyridin-2-yl)methyl]-5-(3-fluorophenyl)-2-(5-methylpyridin-3-yl)pyridine-4-carboxamide | Ki | 0.9 [1], 0.91 [2] |
| N-[(5,6-Dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-phenylpyridine-4-carboxamide | IC50 | 21.0 [1] |
| N-[(5,6-Dimethoxypyridin-2-yl)methyl]-2-(5-methylpyridin-3-yl)-5-phenylpyridine-4-carboxamide | Ki | 0.5 [1], 0.72 [2] |
| [(2R,5R)-5-(8-Fluoroquinolin-4-yl)oxy-2-methylpiperidin-1-yl]-[2-(triazol-2-yl)phenyl]methanone | IC50 | 18.0 [1] |
| [(2R,5R)-5-(8-Fluoroquinolin-4-yl)oxy-2-methylpiperidin-1-yl]-[2-(triazol-2-yl)phenyl]methanone | Ki | 0.55 [1], 0.6 [2] |
| (3R,5S)-1-(Dibenzofuran-2-ylmethyl)-5-(2-fluoro-6-methoxyphenyl)-3-hydroxypyrrolidin-2-one | IC50 | 3.0 [1], 4.0 [2] |
| Lemborexant | Ki | 0.44 [1], 3.0 [2] |
| Empa | Ki | 1.1 [1] |
| Seltorexant | Ki | 9.0 [1] |
| N-Benzyl-2-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]acetamide | IC50 | 8152.0 [1] |
| 2-(3-Phenylpropionyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 10000.0 [1] |
| (4-(6-Chlorobenzothiazole-2-yl)hexahydro-1H-1,4-diazepine-1-yl)(2,6-dimethoxyphenyl)methanone | IC50 | 98.0 [1] |
| (4-(6-Chlorobenzothiazole-2-yl)hexahydro-1H-1,4-diazepine-1-yl)(2,6-dimethoxyphenyl)methanone | Ki | 25.0 [1] |
| 1-(2-Bromophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 100.0 [1], 1995.26 [2] |
| 1-(4-Bromo-2-chloro-phenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-[1,3]dioxan-5-yl)-urea | Ki | 6.31 [1], 5011.87 [2] |
| (E)-N-[(4R,4As,7R,7aR,12bS)-3-(benzenesulfonyl)-4a-hydroxy-9-methoxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | IC50 | 10000.0 [1] |
| (E)-N-[(4R,4As,7R,7aR,12bS)-3-(benzenesulfonyl)-4a-hydroxy-9-methoxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | Ki | 10000.0 [1] |
| 1-(3-Bromophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 1000.0 [1], 10000.0 [2] |
| 1-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-3-(2-propan-2-ylphenyl)urea | Ki | 2511.89 [1], 10000.0 [2] |
| 1-(2,5-Dichlorophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 63.1 [1], 5011.87 [2] |
| 1-(2,6-Dichlorophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 5011.87 [1], 10000.0 [2] |
| 1-(4-Bromophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 251.19 [1], 10000.0 [2] |
| N-[1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)-2,2-dimethyl-propyl]-benzamide | IC50 | 10000.0 [1] |
| 1-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-3-[2-(trifluoromethyl)phenyl]urea | Ki | 100.0 [1], 10000.0 [2] |
| 1-(2,4-Dimethylphenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 125.89 [1], 10000.0 [2] |
| 1-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-3-(2-methoxyphenyl)urea | Ki | 2511.89 [1], 10000.0 [2] |
| 1-(2-Chlorophenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 79.43 [1], 10000.0 [2] |
| 1-[(4S,5S)-2,2-Dimethyl-4-phenyl-1,3-dioxan-5-yl]-3-(2-fluorophenyl)urea | Ki | 398.11 [1], 10000.0 [2] |
| 1-(4-Bromo-2-methylphenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 39.81 [1], 10000.0 [2] |
| 1-(2-Chloro-5-methylphenyl)-3-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]urea | Ki | 63.1 [1], 5011.87 [2] |
| 2-[(4-Tert-Butyl-benzenesulfonyl)-p-tolyl-amino]-N,N-diethyl-acetamide | IC50 | 5.0 [1] |
| 1-(2,4-Dichloro-phenyl)-3-((4S,5S)-2,2-dimethyl-4-phenyl-[1,3]dioxan-5-yl)-urea | Ki | 19.95 [1], 2511.89 [2] |
| 2-[1-[(3,4-Dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]-N-(6-methoxy-2,3-dihydro-1H-inden-1-yl)acetamide | IC50 | 101.0 [1] |
| N-Cyclopropyl-2-[6,7-dimethoxy-1-(naphthalen-2-ylmethyl)-3,4-dihydro-1H-isoquinolin-2-yl]-2-phenylacetamide | IC50 | 80.0 [1] |
| N-Benzyl-2-[1-[(3,4-dichlorophenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]acetamide | IC50 | 281.0 [1] |
| 1-((4S,5S)-2,2-Dimethyl-4-phenyl-[1,3]dioxan-5-yl)-3-(2-iodo-phenyl)-urea | Ki | 79.43 [1], 5011.87 [2] |
| [3-[(4-Fluoro-3-methylphenoxy)methyl]piperidin-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone | Ki | 8.9 [1], 16.0 [2] |
| 2-Amino-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-butan-1-one | IC50 | 10000.0 [1] |
| [(3R)-3-[(4-Fluorophenoxy)methyl]piperidin-1-yl]-(2-methyl-5-phenyl-1,3-thiazol-4-yl)methanone | Ki | 44.0 [1] |
| 2-Benzylamino-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-butan-1-one | IC50 | 910.0 [1] |
| (E)-N-[(4R,4As,7S,7aR,12bS)-3-(benzenesulfonyl)-4a-hydroxy-9-methoxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | IC50 | 10000.0 [1] |
| (E)-N-[(4R,4As,7S,7aR,12bS)-3-(benzenesulfonyl)-4a-hydroxy-9-methoxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | Ki | 10000.0 [1] |
| (S)-1-(2-(1H-Benzo[d]imidazol-2-ylthio)acetyl)-N-(2-(1H-pyrrol-1-yl)phenyl)pyrrolidine-2-carboxamide | Ki | 1.0 [1] |
| 2-Anilino-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethylbutan-1-one | IC50 | 2100.0 [1] |
| N-[1-Benzyl-2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-oxo-ethyl]-benzamide | IC50 | 900.0 [1] |
| 1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-2-(3-phenylpropylamino)butan-1-one | IC50 | 10000.0 [1] |
| 2-[2-Chloro-N-(3,4-dimethoxyphenyl)sulfonyl-5-(dimethylamino)anilino]-N,N-diethylacetamide | IC50 | 5.0 [1] |
| (2R)-2-[(8S)-1-Chloro-3-ethyl-8-[2-[4-(trifluoromethyl)phenyl]ethyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]-N-methyl-2-phenylacetamide | IC50 | 9.0 [1] |
| 2-[(S)-2-(Benzoylamino)-3-phenylpropionyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 195.0 [1] |
| 2-(N-(3,4-Dimethoxyphenyl)sulfonyl-4-methylanilino)-N,N-diethylacetamide | IC50 | 19.0 [1] |
| 2-[(S)-2-(3-Thienylmethylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 35.0 [1] |
| 2-[(S)-2-(2-Thienylmethylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 25.0 [1] |
| 2-[(S)-2-(2-Thiazolylmethylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 59.0 [1] |
| 1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-2-(2-phenylethylamino)butan-1-one | IC50 | 10000.0 [1] |
| 3-Bromo-N-[1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-1-oxo-3-phenylpropan-2-yl]-4-fluorobenzamide | IC50 | 70.0 [1] |
| 2-[(R)-2-(Benzylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 2900.0 [1] |
| 2-[(S)-2-(Benzylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 130.0 [1] |
| 1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-dimethylamino-3-phenyl-propan-1-one | IC50 | 10000.0 [1] |
| 2-Benzyl-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethylbutan-1-one | IC50 | 56.0 [1] |
| 2-(Cyclohexylmethylamino)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethylbutan-1-one | IC50 | 10000.0 [1] |
| 2-[(S)-2-(3-Pyridinylmethylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 240.0 [1] |
| 2-[(S)-2-(Benzylamino)-3-phenylpropionyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 10000.0 [1] |
| 2-[(S)-2-(2-Pyridinylmethylamino)-3,3-dimethylbutanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 1400.0 [1] |
| 2-[(S)-2-(3,5-Dichlorobenzoylamino)-3-phenylpropionyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline | IC50 | 30.0 [1] |
| 2-[(4-Bromophenyl)methyl]-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethylbutan-1-one | IC50 | 2000.0 [1] |